Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction
- PMID: 17974698
- DOI: 10.1136/hrt.2007.124701
Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction
Abstract
Objective: To evaluate the effects of stem cell therapy on restoration of the left ventricular (LV) synchronous contraction in patients with acute myocardial infarction (AMI).
Methods: 40 patients with AMI who underwent successful coronary revascularisation were randomly allocated to the cell infusion or the control group. Evaluations were performed with echocardiographic tissue synchronisation imaging to determine LV dyssynchrony and with cardiac magnetic resonance imaging to estimate LV ejection fraction (LVEF) at baseline and at 6 months. To quantify the severity of systolic LV dyssynchrony, the standard deviations of time to peak systolic velocity of the 12 LV segments (Ts-SD) were calculated.
Results: At 6 months, greater improvements of Ts-SD (DeltaTs-SD: -45.0 (40.2) vs 5.0 (39.9) ms, p<0.001) and LVEF (DeltaLVEF: 6.8% (9.1%) vs -0.2% (6.9%), p = 0.015) relative to the corresponding baseline values were observed in the cell infusion group than in the control group. By multivariate analysis, DeltaTs-SD and baseline LVEF emerged as the independent determinants of LVEF improvement and cell infusion, and baseline Ts-SD as the determinant of DeltaTs-SD improvement. Maximal exercise capacity measured by symptom-limited treadmill testing correlated well with Ts-SD but not with LVEF at 6 months of follow-up.
Conclusion: Stem cell therapy had a favourable effect on the restoration of LV synchronous contraction in patients with AMI.
Comment in
-
Cell therapy in acute myocardial infarction: measures of efficacy.Heart. 2008 Aug;94(8):969-70. doi: 10.1136/hrt.2007.138479. Heart. 2008. PMID: 18625788 No abstract available.
Similar articles
-
Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.Circulation. 2006 Jul 4;114(1 Suppl):I145-51. doi: 10.1161/CIRCULATIONAHA.105.001107. Circulation. 2006. PMID: 16820564 Clinical Trial.
-
Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.Eur Heart J. 2009 Jun;30(11):1313-21. doi: 10.1093/eurheartj/ehp073. Epub 2009 Feb 10. Eur Heart J. 2009. PMID: 19208649 Clinical Trial.
-
Impact of left ventricular dyssynchrony early on left ventricular function after first acute myocardial infarction.Am J Cardiol. 2010 Feb 1;105(3):306-11. doi: 10.1016/j.amjcard.2009.09.028. Epub 2009 Dec 21. Am J Cardiol. 2010. PMID: 20102940
-
Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.Am Heart J. 2011 Oct;162(4):671-7. doi: 10.1016/j.ahj.2011.06.019. Am Heart J. 2011. PMID: 21982659 Review.
-
Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis.Expert Opin Biol Ther. 2010 May;10(5):667-80. doi: 10.1517/14712591003716437. Expert Opin Biol Ther. 2010. PMID: 20384520 Review.
Cited by
-
Mid- to long-term efficacy and safety of stem cell therapy for acute myocardial infarction: a systematic review and meta-analysis.Stem Cell Res Ther. 2024 Sep 11;15(1):290. doi: 10.1186/s13287-024-03891-1. Stem Cell Res Ther. 2024. PMID: 39256845 Free PMC article.
-
Reparative resynchronization in ischemic heart failure: an emerging strategy.Expert Opin Biol Ther. 2014 Aug;14(8):1055-60. doi: 10.1517/14712598.2014.922536. Epub 2014 May 19. Expert Opin Biol Ther. 2014. PMID: 24840208 Free PMC article.
-
Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction.J Physiol. 2013 Sep 1;591(17):4335-49. doi: 10.1113/jphysiol.2013.252288. Epub 2013 Apr 8. J Physiol. 2013. PMID: 23568891 Free PMC article.
-
Stem cell treatment for acute myocardial infarction.Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD006536. doi: 10.1002/14651858.CD006536.pub4. Cochrane Database Syst Rev. 2015. PMID: 26419913 Free PMC article. Review.
-
The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction.Stem Cell Res Ther. 2013 Jul 12;4(4):82. doi: 10.1186/scrt233. Stem Cell Res Ther. 2013. PMID: 23849537 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical